Literature DB >> 24291379

Is there a tradeoff in using modified high tangent field radiation for treating an undissected node-positive axilla?

Himanshu Nagar1, Lili Zhou2, Bertrand Biritz2, Cristina Sison3, Jenghwa Chang2, Michael Smith2, Dattatreyudu Nori2, K S Clifford Chao2, Mary Katherine Hayes2.   

Abstract

INTRODUCTION: Recent data are changing axillary management in patients with 1 to 2 positive sentinel nodes. The proposed omission of completion axillary node dissection calls into question the need for axillary nodal irradiation. This study evaluates the difference in dose to the lung and heart and risk of radiation pneumonitis (RP) for patients treated with standard tangent fields (STF) compared with modified high tangent fields (MHTF).
MATERIALS AND METHODS: Plans of 30 patients treated with STF were evaluated. A second plan (MHTF) was developed to include axillary levels I (Ax1) and II (Ax2). Ax1 and Ax2 volumes were contoured based on the RTOG (Radiation Therapy Oncology Group) Atlas guidelines. Dose-volume histograms of the 2 plans were used to compare doses received by Ax1, Ax2, lung, and heart volumes. The risk of RP was calculated using normal tissue complication probability (NTCP) modeling.
RESULTS: The D95 (dose to 95% of volume) received by Ax1 and Ax2 volumes increased from 16.38 Gy and 5.71 Gy for STF to 49.38 Gy and 48.08 Gy for MHTF, respectively. Mean lung dose increased from 5.40 Gy for STF to 9.47 Gy for MHTF. Mean ipsilateral lung V5, V10, and V20 values increased from 19%, 14%, and 10%, respectively, for STF, to 32%, 24%, and 18%, respectively, for MHTF. Mean heart dose increased from 1.98 Gy for STF to 3.93 Gy for MHTF. Mean heart V25 and V30 values increased from 2% and 1%, respectively, for STF, to 4% and 3%, respectively, for MHTF. NTCP for RP increased from near 0% for STF to 1% for MHTF.
CONCLUSION: Modified high tangent fields are necessary for definitive coverage of Ax1 and Ax2. This technique increases mean ipsilateral lung and heart doses as well as the V5, V10, and V20 of ipsilateral lung and the V25 and V30 of the heart. Risk of RP remains low by use of MHTF.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axillary radiation; Cardiac; Pulmonary toxicity; Tangent field

Mesh:

Year:  2013        PMID: 24291379     DOI: 10.1016/j.clbc.2013.10.004

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  4 in total

1.  The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.

Authors:  Justin M Mann; Xian Wu; Paul Christos; Himanshu Nagar
Journal:  Clin Breast Cancer       Date:  2017-09-19       Impact factor: 3.225

2.  Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy.

Authors:  Bence Bukovszky; János Fodor; Zoltán Mátrai; Bence Dorogi; Zsuzsanna Zongor; Dalma Mihály; Csaba Polgár; Tibor Major
Journal:  Rep Pract Oncol Radiother       Date:  2022-07-29

3.  High Tangent Radiation Therapy With Field-in-Field Technique for Breast Cancer.

Authors:  Hidekazu Tanaka; Masaya Ito; Takahiro Yamaguchi; Kae Hachiya; Takahiko Yajima; Masashi Kitahara; Katsuya Matsuyama; Satoshi Goshima; Manabu Futamura; Masayuki Matsuo
Journal:  Breast Cancer (Auckl)       Date:  2017-09-20

4.  Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer.

Authors:  Kai J Borm; Markus Oechsner; Mathias Düsberg; Gabriel Buschner; Weber Wolfgang; Stephanie E Combs; Marciana N Duma
Journal:  Strahlenther Onkol       Date:  2020-06-02       Impact factor: 3.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.